Streetbeat News

Equity Actions

BN

Brookfield (NYSE:BN) has seen a 12.35% increase in short interest since its last report, with 26.98 million shares sold short, representing 1.82% of its float. It would take about 9.12 days to cover all short positions. While an increase in short interest can indicate bearish sentiment, Brookfield has less short interest compared to its peer group average of 3.11%. The rise in short interest doesn't necessarily predict a stock price drop.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 5:15 pm

ARGT

EDN

MELI

TEO

YPF

Javier Milei was inaugurated as Argentina's president, promising radical economic changes amid a hyperinflationary crisis. Milei plans to cut government spending to combat inflation projected to potentially reach 15,000%. U.S. officials attended the inauguration, indicating potential for improved U.S.-Argentina relations. Since Milei's election, Argentine stocks have surged, with the Global X MSCI Argentina ETF (ARGT) up 20%, and companies like EDN, YPF, TEO, and MELI showing significant gains.

Portfolio Pulse from Piero Cingari

December 11, 2023 | 5:12 pm

GGE

Green Giant shares have declined following the announcement of a proposed public offering. The offering could potentially dilute existing shareholders' equity and indicates the company may need additional capital.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 5:07 pm

COIN

Ex-Coinbase professionals have established a $500 million fund, C1, to acquire secondary shares in crypto firms like Animoca Brands and Chainalysis at discounts of 50% to 80%. The fund targets companies valued at $300 million or more and plans to invest $20 million to $50 million per deal. Animoca Brands, now valued at $7.8 billion, and Chainalysis, valued at $8.4 billion, are potential targets. The crypto market is showing signs of recovery, with Bitcoin crossing $40,000 and anticipation of a U.S.-regulated Bitcoin ETF and a Bitcoin network upgrade.

Portfolio Pulse from Murtuza Merchant

December 11, 2023 | 4:01 pm

AMGN

Amgen (NASDAQ:AMGN) is analyzed against its peers in the Biotechnology sector, showing a mixed valuation with a low P/E ratio, high P/B ratio, and low P/S ratio. Amgen's ROE, EBITDA, gross profit, and revenue growth are strong compared to the industry, but it has a higher debt-to-equity ratio, indicating potential financial risk.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 4:00 pm

ADSK

The analysis of Autodesk (NASDAQ:ADSK) and its competitors in the Software industry reveals that ADSK has a lower P/E ratio than the industry average, suggesting potential value. However, its high P/B ratio may indicate overvaluation in terms of book value. The P/S ratio suggests possible undervaluation based on sales performance. Autodesk's ROE is above the industry average, but its EBITDA, gross profit, and revenue growth are below the industry average, which may signal financial challenges or lower profitability. Autodesk's D/E ratio is moderate compared to its top 4 peers.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 4:00 pm

DASH

ZM

DoorDash Inc (DASH) and Zoom Video Communications Inc (ZM) shares are moving in opposite directions after the Nasdaq announced the annual reconstitution of the Nasdaq-100 Index. DoorDash was added to the index, while Zoom was removed. As a result, DoorDash shares were up 2.63% at $102.63, and Zoom shares were down 1.88% at $71.68.

Portfolio Pulse from Adam Eckert

December 11, 2023 | 3:46 pm

DASH

DoorDash shares are trading higher following the announcement that the company will be added to the Nasdaq-100 Index, which is often seen as a positive indicator of a company's growth and stability, potentially leading to increased investor interest.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 3:39 pm

BNPQF

CRM

MSFT

Mistral AI, a French startup and rival to OpenAI, has closed a $415 million Series A funding round led by Andreessen Horowitz, with participation from Lightspeed Venture Partners, Salesforce, BNP Paribas, CMA-CGM, General Catalyst, Elad Gil, and Conviction. This funding values the company at an estimated $2 billion. Mistral AI is developing foundational models and a business platform focused on open technology. The company has also influenced the EU's AI Act debate, advocating for exemptions for foundational models. Microsoft, a significant investor in OpenAI, was not part of this funding round.

Portfolio Pulse from Surbhi Jain

December 11, 2023 | 3:38 pm

CYTO

Altamira Therapeutics Ltd (NASDAQ:CYTO) stock plummeted by 50% to $0.20 after announcing strategic changes, including a partial spin-off of its Bentrio business and a 20-for-1 reverse stock split scheduled for December 13. The company sold a 51% stake in Altamira Medica AG for approximately $2.3 million, retaining Bentrio, a key asset with expected sales growth from 2024. Altamira is also seeking partnerships for its inner ear therapeutics, particularly AM-125, which is in Phase 2 trials.

Portfolio Pulse from Henry Khederian

December 11, 2023 | 3:35 pm